Eiger BioPharmaceuticals announces proposed public offering of common stock
Eiger BioPharmaceuticals announced it has commenced an underwritten public offering of its common stock. Eiger intends to grant underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering on the same terms and conditions. May 23, 2018